Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Holtzman

Showing results (511-520 of 742) with videos related to

Pageof 75
Sort By:
Molecular Neurodegeneration|April 23, 2013
In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysisJason D Ulrich, Jack M Burchett, Jessica L Restivo, et al.
Nature Aging|September 21, 2023
The VCAM1-ApoE pathway directs microglial chemotaxis and alleviates Alzheimer's disease pathologyShun-Fat Lau, Wei Wu, Hiu Yi Wong, et al.
Alzheimer'S Research & Therapy|September 19, 2015
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohortMaartje I Kester, Charlotte E Teunissen, Courtney Sutphen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 16, 2011
In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic miceKaoru Yamada, John R Cirrito, Floy R Stewart, et al.
The Journal of Experimental Medicine|November 26, 2014
Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's diseaseJee Hoon Roh, Hong Jiang, Mary Beth Finn, et al.
Molecular Neurodegeneration|April 14, 2007
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphismsSuzanne E Wahrle, Aarti R Shah, Anne M Fagan, et al.
Cell Reports|May 5, 2015
Chronic optogenetic activation augments aβ pathology in a mouse model of Alzheimer diseaseKaoru Yamamoto, Zen-Ichi Tanei, Tadafumi Hashimoto, et al.
The Journal of Clinical Investigation|June 17, 2020
Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegenerationMaud Gratuze, Cheryl Eg Leyns, Andrew D Sauerbeck, et al.
Annals of Neurology|August 9, 2011
Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer diseaseRawan Tarawneh, Gina D'Angelo, Elizabeth Macy, et al.
Neurobiology of Disease|April 20, 2005
Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-betaMasayuki Morikawa, John D Fryer, Patrick M Sullivan, et al.
Pageof 75

Showing results (511-520 of 742) with videos related to

Sort By:
Pageof 75
Molecular Neurodegeneration|April 23, 2013
In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysisJason D Ulrich, Jack M Burchett, Jessica L Restivo, et al.
Nature Aging|September 21, 2023
The VCAM1-ApoE pathway directs microglial chemotaxis and alleviates Alzheimer's disease pathologyShun-Fat Lau, Wei Wu, Hiu Yi Wong, et al.
Alzheimer'S Research & Therapy|September 19, 2015
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohortMaartje I Kester, Charlotte E Teunissen, Courtney Sutphen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 16, 2011
In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic miceKaoru Yamada, John R Cirrito, Floy R Stewart, et al.
The Journal of Experimental Medicine|November 26, 2014
Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's diseaseJee Hoon Roh, Hong Jiang, Mary Beth Finn, et al.
Molecular Neurodegeneration|April 14, 2007
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphismsSuzanne E Wahrle, Aarti R Shah, Anne M Fagan, et al.
Cell Reports|May 5, 2015
Chronic optogenetic activation augments aβ pathology in a mouse model of Alzheimer diseaseKaoru Yamamoto, Zen-Ichi Tanei, Tadafumi Hashimoto, et al.
The Journal of Clinical Investigation|June 17, 2020
Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegenerationMaud Gratuze, Cheryl Eg Leyns, Andrew D Sauerbeck, et al.
Annals of Neurology|August 9, 2011
Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer diseaseRawan Tarawneh, Gina D'Angelo, Elizabeth Macy, et al.
Neurobiology of Disease|April 20, 2005
Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-betaMasayuki Morikawa, John D Fryer, Patrick M Sullivan, et al.
Pageof 75